Ameritas Investment Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Ameritas Investment Partners’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	+3,847	New	+$200K	0.01%	1274
2025 Q2	–	Sell	-3,649	Closed	-$81K	–	3272
2025 Q1	$81K	Hold	3,649	–	–	﹤0.01%	1839
2024 Q4	$72.2K	Hold	3,649	–	–	﹤0.01%	1972
2024 Q3	$91.2K	Buy	+3,649	New	+$88.9K	﹤0.01%	1857
2024 Q2	–	Sell	-3,094	Closed	-$61K	–	3183
2024 Q1	$61K	Hold	3,094	–	–	﹤0.01%	2034
2023 Q4	$54.3K	Hold	3,094	–	–	﹤0.01%	2126
2023 Q3	$53.7K	Buy	3,094 +816	+36%	+$13.7K	﹤0.01%	2059
2023 Q2	$32.1K	Hold	2,278	–	–	﹤0.01%	2297
2023 Q1	$24.5K	Hold	2,278	–	–	﹤0.01%	2386
2022 Q4	$31.9K	Hold	2,278	–	–	﹤0.01%	2331
2022 Q3	$29K	Hold	2,278	–	–	﹤0.01%	2323
2022 Q2	$22K	Hold	2,278	–	–	﹤0.01%	2508
2022 Q1	$23K	Hold	2,278	–	–	﹤0.01%	2495
2021 Q4	$27K	Hold	2,278	–	–	﹤0.01%	2498
2021 Q3	$26K	Hold	2,278	–	–	﹤0.01%	2559
2021 Q2	$32K	Hold	2,278	–	–	﹤0.01%	2467
2021 Q1	$42K	Hold	2,278	–	–	﹤0.01%	2187
2020 Q4	$40K	Hold	2,278	–	–	﹤0.01%	2109
2020 Q3	$35K	Buy	2,278 +598	+36%	+$11.2K	﹤0.01%	2052
2020 Q2	$43K	Buy	1,680 +705	+72%	+$14.7K	﹤0.01%	1923
2020 Q1	$15K	Hold	975	–	–	﹤0.01%	2335
2019 Q4	$11K	Hold	975	–	–	﹤0.01%	2693
2019 Q3	$8K	Hold	975	–	–	﹤0.01%	2810
2019 Q2	$13K	Buy	975 +440	+82%	+$6.83K	﹤0.01%	2685
2019 Q1	$10K	Hold	535	–	–	﹤0.01%	2695
2018 Q4	$15K	Hold	535	–	–	﹤0.01%	2487
2018 Q3	$14K	Buy	+535	New	+$10.4K	﹤0.01%	2689

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Ameritas Investment Partners's KNSA Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 3,847 shares worth $246K. The stake represents 0.01% of the portfolio and ranks #1274 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in KNSA as recently as Q1 2025.

Ameritas Investment Partners first reported a position in KNSA in Q3 2018 and has held it in 27 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Ameritas Investment Partners held 3,847 shares of Kiniksa Pharmaceuticals worth $246K as of Q2 2026.
Kiniksa Pharmaceuticals was a new Ameritas Investment Partners position in Q2 2026.
Kiniksa Pharmaceuticals made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1274 holding.
Ameritas Investment Partners first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and has held it in 27 quarters since.
266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.